Pharmaceutical industry news

Handol Kim to Deliver Keynote at BioAlberta’s Health and Life Sciences Showcase

Experimental MS drug bests approved therapy in cutting relapses in 2 trials

Variational AI at BIONATION 2026

Mark Your Calendar: The WBUR Breakfast Club Brings Together Founders and CEOs Reshaping Fashion, Gaming and Biotech This Fall

Adaptive Biotechnologies (NASDAQ: ADPT) director reports stock gift, still holds 66,100 shares

Variational AI at ALL IN 2026

How to Properly Leverage FDA Flexibility Canva

UBC and Langara College formalize partnership to strengthen student pathways and success

SHAANXI MICOT PHARMACEUTICAL TECHNOLOGY CO., LTD.

AbbVie's Rinvoq Restores 80% Hair Growth in Severe Alopecia Areata Phase 3 Trial; South Korean Generic Makers on Alert

El proyecto TROPOSplice, coordinado por el investigador William Joyce en el CNIC, obtiene una ERC Starting Grant

Revolution Medicines Announces NEJM Publication of Phase 1/2 RASONQUE Data Supporting Ongoing Phase 3 RASolve 301 Trial in RAS Mutant NSCLC

#RASSEGNASTAMPA L’Archivio Storico del Policlinico protagonista su TGR Lombardia

An experimental lung cancer drug held disease in check for 89% of patients in one group.

Health Care Up on Biotech Momentum - Health Care Roundup

Teva Drug Rises to the Gluten Challenge, Stopping Intestinal Damage in Celiac Disease Trial

Clinical Trial Finds Less-Intensive Drug Combination Is More Effective Than Standard of Care for AML

HyGen Promotes Omid Ghobadi to COO as Pharmaceutical Distributor Expands

Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biotech Firm Buys Former Merrimack Anheuser-Busch Brewery for $47 million

Plant-based eczema drug firm Devonian (DVHGF) lines up U.S. IPO, but only if one condition is met.

Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol

Key differences in bowel cancer before 50

Repetitive Transcranial Magnetic Stimulation: A Potential Treatment for Obesity in Patients with Schizophrenia

Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era

Consun Pharmaceutical Group (SEHK:1681) Lifts Earnings And Dividend On A Valuation That Still Looks Cheap

FDA orders recall of Arcan Bitters over undeclared drug substance

Senators Demand Federal Probe Linking Foreign Drug Makers To U.S. Recalls

INVENTIVA

Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

UC1 Stock Price and Chart — HAM:UC1

Is West Pharmaceutical Services (WST) Undervalued Or Already Fully Valued?

St. Louis biotech raises $10M and names new CEO as cancer treatment advances

Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex reduces cocaine craving in patients with cocaine use disorder

FDA orders recall of Arcan Bitters over undeclared sildenafil content

FDA Adds Its Strongest Warning to a Common IV Iron Drug Over Dangerously Low Phosphate Levels

Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report

Effectiveness of transcranial magnetic stimulation for posttraumatic stress disorder: A multisite, propensity-matched cohort study of treatment parameters

Solving Batch Variability Issues

FIFARMA W.A.I.T. Indicator 2026: do tempo de espera à oportunidade de avançar

Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division

Intermountain Health Unveils Plans for New Intermountain LDS Hospital in Downtown Salt Lake City

3D retina model reveals cause of vision loss in Batten disease

McCloud Remedy project recovery plan: review update

Conclusions and recommendations from the independent review of the NHS Business Service Authority’s...

FIFARMA W.A.I.T. Indicator 2026: from waiting time to an opportunity to move forward

Pirbright expertise helps uncover 3,800-year history of sheeppox

Stopping chronic pain before it starts

Withdrawn | Cancer Accelerated Approvals

American shoppers are so rattled by surging FDA recalls that 67% now avoid a whole food category after just one notice

Biotech Expansion at Levit Green

Non-invasive brain stimulation for suicidal ideation: a systematic review and metanalysis of the current literature

TScan Therapeutics sheds majority of staff, pauses Phase 3 trial amid funding shortfall

An exploratory randomized, double-blind trial of accelerated deep TMS for patients with suicidal thoughts and behaviors

Marked reduction in suicidality and depression in a transcranial magnetic stimulation non-responder after augmenting with a standard available D-cycloserine dose

Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQ

Mumbai: FDA Suspends Eat Club, Rani Creators Licences Over Food Safety And Hygiene Violations

Maharashtra FDA Suspends Licences of 2 More Mumbai Food Establishments Over Safety Lapses

UKHSA spend over £500: 2026

Details of UK Health Security Agency (UKHSA) Government Procurement Card (GPC) transactions over £50...

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal